Skip to main content
. 2021 Jun 4;10(1):310–321. doi: 10.1080/21623945.2021.1933297

Table 3.

The hub genes miRNA expressed in normal adipose tissue using BioGPS and related disease by CTD

Groups Hub genes Adipose tissue Adipose tissue omental Related Disease Inference Score
BMI > 35 kg/m2:DM VS NDM TRDN 0.37 ± 0.19 0.48 ± 0.09 Weight Loss 37.25
  PLN 10.13 ± 2.16 6.33 ± 1.16 Glucose Intolerance 37.13
  MYH11 9.08 ± 1.83 9.36 ± 0.60 Weight Loss 100.69
BMI 18–24.9 kg/m2:DM VS NDM  COL4A2 17.04 ± 0.69 16.53 ± 0.27 Weight Loss 92.25
  COL6A6 5.80 ± 2.80 5.21 ± 1.05 Diabetes Mellitus 16.00
  ACACB 6.25 ± 1.61 9.03 ± 0.19 Insulin Resistance 85.45
  GLUL 11.26 ± 0.94 11.23 ± 0.77 Weight Loss 175.47
  ELOVL7 9.41 ± 1.43 1.19 ± 0.37 Weight Loss 77.78
  MYH2 −0.76 ± 3.09 −0.23 ± 1.19 Insulin Resistance 40.55
DM: BMI>35 kg/m2 VS 18–24.9 kg/m2 CD36 19.01 ± 0.75 16.29 ± 0.41 Weight Loss 239.26
  FCGR2A 4.96 ± 1.16 2.48 ± 1.00 Weight Loss 34.41
  PTPRC 5.57 ± 1.42 2.78 ± 0.35 Weight Loss 84.92
  CD163 0.86 ± 0.59 0.7 ± 0.12 Weight Loss 98.07
  MS4A6A 7.76 ± 1.17 7.56 ± 1.00 Glucose Intolerance 33.85
DM: BMI 24.9–35 kg/m2 VS 18–24.9 kg/m2 TNNC2 1.14 ± 0.37 0.42 ± 0.17 Weight Loss 70.86
  MYH2 −0.76 ± 3.09 −0.23 ± 1.19 Insulin Resistance 40.55

CTD: comparative toxicogenomics database; BMI: Body mass index; DM: type 2 diabetes; NDM: non-diabetes. mean± SD: miRNA expression